Funding for this research was provided by:
Sub-Saharan African Network for TB/HIV Research Excellence (DEL-15-006)
National Institutes of Health (R01AI124968, R01AI124968)
University of Washington/Fred Hutch Center for AIDS Research (AI027757)
Received: 6 May 2021
Accepted: 1 February 2022
First Online: 11 February 2022
: The study received ethical approval from the KEMRI Scientific and Ethical Review Unit (KEMRI/SERU/CGMRC-C/051/3280), the Human Subjects Division at the University of Washington (STUDY00001808), and the Oxford Tropical Research Ethics Committee (OxTREC) at the University of Oxford (Reference: 46–16). All participants provided written informed consent. This study was conducted according to recognised ethical principles and guidelines, including the Declaration of Helsinki and Good Clinical Practice guidelines.
: Not applicable.
: The authors declare they have no competing interests.The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government’. This manuscript was submitted for publication with the permission from the Director of the Kenya Medical Research Institute (KEMRI).